VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here : IndiaNotes >> Research & Analysis >> Companies >> Laurus Labs Ltd. >> Research

Jainam Wealth recommend 'Avoid' on the Laurus Labs IPO

Jainam Research | 05 Dec, 2016  | Follow Author | Add to my Favourites 
  • Rate this article
    (Average Rating 5.0 Based on 1 ratings)



We at Jainam Wealth recommend our Investors to “AVOID” to the Laurus Labs Ltd IPO. considering only ARVs, Hepatitis C & Oncology contributing 92% in FY16, top 5 customers contributing 68% of revenue, lower profitability margins and higher debt level.

 

Price Band Rs.426 - 428. Issue open on 06th December and close to 08th December. Market Lot 35 Shares.




 
BSE
507.35 -11.85
(-2.28%)
NSE
512.90 +9.55
(1.90%)
Read More
About Jainam Research

Jainam Research was incorporated in 2003 with the vision to be the most preferred organization providing all financial services across the country. The foundation is on "Value" Systems - "Value" addition to Corporate, Retails and HNI Individuals through superior Wealth Creation Practices.

 

For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor IndiaNotes.com accept any liability whatsoever arising from the use of any of the above contents.




Technical Calls

What are technical calls?

Other Articles


Have a question?